The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae)

被引:123
作者
Cock, I. E. [1 ,2 ]
机构
[1] Griffith Univ, Biomol & Phys Sci, Brisbane, Qld 4111, Australia
[2] Griffith Univ, Environm Futures Ctr, Brisbane, Qld 4111, Australia
关键词
Antioxidant; Anticancer; Inflammation; Antimicrobial; Diabetes; Medicinal plants; NITRIC-OXIDE; IN-VITRO; ANTIOXIDANT PROPERTIES; ANTIDIABETIC ACTIVITY; CHEMICAL EXAMINATION; GALLIC ACID; HEPATOCELLULAR-CARCINOMA; CARDIOVASCULAR-DISEASE; ANTIMICROBIAL ACTIVITY; AYURVEDIC FORMULATION;
D O I
10.1007/s10787-015-0246-z
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plants of the genus Terminalia are amongst the most widely used plants for traditional medicinal purposes worldwide. Many species are used for their antibacterial, antifungal, antiprotozoal, antiviral, antidiarrhoeal, analgesic, antimalarial, antioxidant, antiinflammatory and anticancer activities. Wound healing and cardiovascular effects have also been credited to some species. Many Terminalia species have multiple beneficial effects for multiple diseases and ailments. Indeed, the Indian species Terminalia chebula is known as the king of plants in Ayurveda due to its broad range of medicinal uses. However, apart from the reported ethnopharmacological uses of many Terminalia species, surprisingly few studies have rigorously examined this important genus for their medical properties/mechanisms and phytochemistry. This is likely due to the high tannin content common to many Terminalia species and the perception that these tannins may be responsible for much of their beneficial properties. As the complexities of tannins make them poor candidates for drug design, most interest in Terminalia species has been for their pharmacognostic and nutraceutical value and they have often been overlooked as potentials for drug discovery. However, recent reports have identified many other interesting phytochemicals and demonstrated that these may be responsible for several of the reported bioactivities of the Terminalia species used in traditional medicinal systems. The last decade has seen a large increase in the number of studies into the use of Terminalia species as therapeutic agents. Several species used in Ayurvedic medicine (Terminalia arjuna, Terminalia bellerica, Terminalia catappa, T. chebula) in particular have received much recent attention. Similarly, recent reports have also highlighted the medicinal potential of species from Africa, Australia and the Americas. The aim of this report is to summarise the recent research into the medicinal properties, phytochemistry and therapeutic mechanisms of Terminalia species and thus to highlight and direct future areas of research into the medicinal activities of this important genus.
引用
收藏
页码:203 / 229
页数:27
相关论文
共 201 条
[1]  
Adetunji VO, 2010, J MED PLANTS RES, V4, P2348
[2]  
Agbedahunsi J. M., 2006, African Journal of Traditional, Complementary and Alternative Medicines, V3, P51
[3]  
Agrawal S., 2011, FREE RADIC ANTIOX, V1, P62
[4]  
Ahmed SM., 2005, Inter J Pharma Tech, V4, P36
[5]   Strand scission in DNA induced by curcumin in the presence of Cu(II) [J].
Ahsan, H ;
Hadi, SM .
CANCER LETTERS, 1998, 124 (01) :23-30
[6]   Terminalia catappa Extract Enhances Erythropoiesis in Adult Balb C Mice [J].
Aimola, I. A. ;
Inuwa, H. M. ;
Mamman, A. I. ;
Habila, N. ;
Agbaji, A. S. ;
Omoniwa, D. .
JOURNAL OF MOLECULAR BIOLOGY RESEARCH, 2011, 1 (01) :40-46
[7]   Screening of crude extracts of six medicinal plants used in South-West Nigerian unorthodox medicine for anti-methicillin resistant Staphylococcus aureus activity [J].
Akinyemi K.O. ;
Oladapo O. ;
Okwara C.E. ;
Ibe C.C. ;
Fasure K.A. .
BMC Complementary and Alternative Medicine, 5 (1)
[8]   Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications [J].
Alarcn de la Lastral, C. ;
Villegas, I. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :1156-1160
[9]  
Alayande L. B., 2011, Sokoto Journal of Veterinary Sciences, V9, P11
[10]  
Ali A, 2003, PHARMAZIE, V58, P932